Reduced expression of β-catenin inhibitor Chibby in colon carcinoma cell lines

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:mihu0907
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To analyse the Chibby expression and its function in colon carcinoma cell lines and colorectal carcinoma (CRC).METHODS: Chibby expression levels were investigated by quantitative RT-PCR in a panel of seven different colon carcinoma cell lines. By sequencing, we analysed mutational status of Chibby. To test whether Chibby exhibited effects on β-catenin signalling in colon carcinoma cells, we transfected SW480 cells with Chibby expression plasmid and, subsequently, analysed activity of β-catenin and tested for alterations in cellular phenotype. In addition, we examined Chibby mRNA levels in samples of colorectal carcinomas and adjacent normal tissues by using quantitative RT-PCR and hybridised gene chips with samples from CRC and normal tissues.RESULTS: Chibby mRNA expression was strongly downregulated in colon carcinoma cell lines in comparison to normal colon epithelial cells and no mutation in any of the examined colon carcinoma cell lines was found. Further, we could show that Chibby inhibited β-catenin activity in TOPflash assays when over-expressed in SW480 cells. Proliferation and invasion assays with Chibby transfected SW480 cells did not reveal profound differences compared to control cells. In contrast to these in vitro data, quantitative RT-PCR analyses of Chibby mRNA levels in CRC tumor samples did not show significant differences to specimens in adjacent non-cancerous tissue.Consistent with these findings, gene chips analysing tissue samples of tumors and corresponding normal tissue did not show altered Chibby expressionCONCLUSION: Altered Chibby expression might beobserved in vitro in different colon carcinoma cell lines.However, this finding could not be confirmed in vitro in CRC tumors, indicating that Chibby is not likely to promote CRC tumor development or progression. As Chibby is an important inhibitor of β-catenin signalling, our data implicate that the usability of colon carcinoma cell lines for in vitro studies analysing the Wnt/β-catenin pathway in colorectal carcinoma needs extensive verification.
其他文献
根据国家癌症中心的最新数据,前列腺癌(PCa)自2008年起成为泌尿系统中发病率最高的肿瘤,在男性恶性肿瘤发病率中排名第六位,病死率在所有男性恶性肿瘤中排第九位。因此选择安全、有效的诊断方法检测PCa的发生是非常必要的。目前主要采用直肠指检、血清前列腺特异性抗原(PSA)、经直肠超声、MRI波谱成像、前列腺穿刺活检等进行临床筛查和诊断PCa,其中前列腺系统穿刺活检是诊断PCa最可靠的检查,是诊断P
期刊
目的 研究正视人群与近视人群阅读中文简体字与繁体字时产生的短暂性近视的量,以及其回退时间的差异.方法 实验研究.随机选择18~28岁的近视者18人,等效球镜度为(-3.74±1.22)D;正视者18人,等效球镜度为(-0.14±0.22)D.应用Grand-Seiko WAM-5500分别测量阅读两种大小(12 pt;8 pt)中文简体字与繁体字4组视标短暂性近视的量及其回退时间,要求阅读距离40
目的评价玻璃体切除术治疗慢性肾衰竭患者增生性糖尿病视网膜病变的临床效果。方法回顾性分析慢性肾衰竭患者增生性糖尿病视网膜病变行玻璃体切除术21例(21只眼)的临床资料。结果术后随访3个月,末次随访最佳矫正视力较术前提高者20只眼(95.24%),下降者1只眼(4.76%)。术后最佳矫正视力(log MAR)术前平均为2.05±0.78,末次随访平均为0.68±0.66,较术前明显提高,差异有统计学意
经鼻高流量氧疗(HFNC)是近期一种新型的氧疗方式,因其独特的生理学效应受到广大医务人员的青睐。本文在复习大量文献基础上,总结出HFNC在改善氧合和舒适性方面有明显优势,在临床中被广泛应用于急性呼吸衰竭患者、术后或拔管后呼吸衰竭的患者及一些呼吸道有创操作中。但HFNC在改善通气方面并没有相关文献报道其有效性,并且对于短时间应用HFNC后呼吸、循环和氧合状况无显著改善的低氧性呼吸衰竭患者,应及早更换
期刊
目的:研究临床护理路径在心外科患者中应用的效果,为后期临床治疗提供依据.方法:选取我院在2017年4月-2018年4月期间收治的94例心外科患者,采取抛硬币的方式随机分为研究组和
舒尼替尼是一种靶向多种受体酪氨酸激酶(RTK)抑制剂,用于治疗晚期肾细胞癌、伊马替尼不耐受和伊马替尼耐药的难治性胃肠道间质瘤。舒尼替尼常见的不良反应包括疲劳与乏力,皮肤黏膜不良反应(手足皮肤反应、皮肤颜色改变、头发色素脱失、甲下线状出血、口腔炎、脱发等),心血管不良反应(高血压、有/无症状的左心室射血分数下降、心功能衰竭等),以及甲状腺功能减退等。舒尼替尼致疲劳与乏力的机制可能与其抑制一磷酸腺苷依
丙硫氧嘧啶(PTU)致抗中性粒细胞胞质抗体(ANCA)相关血管炎(AAV)(PTU-AAV)占抗甲状腺药物所致血管炎的80%~90%,可累及呼吸、肾脏、皮肤、肌肉、神经、胃肠和五官等系统,临床表现为发热、乏力、体重下降、肌肉关节疼痛、紫癜样皮损、血尿、结膜炎,严重时可致肺泡出血、急性肾衰竭甚至危及生命,实验室检查血清ANCA阳性。PTU与髓过氧化物酶(MPO)相互作用可能是PTU-AAV的发生机制